New minocycline foam may help with rosacea
An application is being made to the FDA
26th February 2020
A new topical minocycline 1.5% foam appears effective against moderate-to-severe papulopustular rosacea, according to two randomised trials.
Results from the two studies have been submitted to the US FDA as part of a new-drug application.
Oral antibiotics, specifically doxycycline and minocycline, are also frequently used but may have gastrointestinal and other side effects.
Researchers from Foamix Pharmaceuticals conducted two identical randomised phase-3 12-week trials, with about 500 participants randomised to receive